WJ05129

· Suzhou Junjing BioSciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WJ05129, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of WJ05129 in Advanced Malignant Solid Tumors [Phase 1, Phase 2]